LINC00324 in cancer: Regulatory and therapeutic implications
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1039366
Abstract: LINC00324 is a 2082 bp intergenic noncoding RNA. Aberrant expression of LINC00324 was associated with the risk of 11 tumors and was closely associated with clinicopathological features and prognostic levels of 7 tumors. LINC00324 can… read more here.
Keywords: regulatory therapeutic; signaling pathway; linc00324; linc00324 cancer ... See more keywords